Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2010 1
2011 1
2013 1
2014 2
2015 3
2016 1
2017 3
2018 7
2019 9
2020 6
2021 12
2022 10
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Targeting BRCA and PALB2 in Pancreatic Cancer.
Anbil S, Reiss KA. Anbil S, et al. Among authors: reiss ka. Curr Treat Options Oncol. 2024 Mar;25(3):346-363. doi: 10.1007/s11864-023-01174-0. Epub 2024 Jan 4. Curr Treat Options Oncol. 2024. PMID: 38311708 Review.
Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival.
Boursi B, Wileyto EP, Mamtani R, Domchek SM, Golan T, Hood R, Reiss KA. Boursi B, et al. Among authors: reiss ka. JAMA Netw Open. 2023 Nov 1;6(11):e2345013. doi: 10.1001/jamanetworkopen.2023.45013. JAMA Netw Open. 2023. PMID: 38010655 Free PMC article.
Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers.
Wineland D, Le AN, Hausler R, Kelly G, Barrett E, Desai H, Wubbenhorst B, Pluta J, Bastian P, Symecko H, D'Andrea K, Doucette A, Gabriel P, Reiss KA, Nayak A, Feldman M, Domchek SM, Nathanson KL, Maxwell KN; Regeneron Genetics Center; Penn Medicine Biobank. Wineland D, et al. Among authors: reiss ka. JCO Precis Oncol. 2023 Aug;7:e2300036. doi: 10.1200/PO.23.00036. JCO Precis Oncol. 2023. PMID: 37535879 Free PMC article.
The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 after Progression on Rucaparib.
Brown TJ, Yablonovitch A, Till JE, Yen J, Kiedrowski LA, Hood R, O'Hara MH, Teitelbaum U, Karasic TB, Schneider C, Carpenter EL, Nathanson K, Domchek SM, Reiss KA. Brown TJ, et al. Among authors: reiss ka. Clin Cancer Res. 2023 Dec 15;29(24):5207-5216. doi: 10.1158/1078-0432.CCR-23-1467. Clin Cancer Res. 2023. PMID: 37486343
Advancements in Systemic Therapy for Pancreatic Cancer.
Brown TJ, Reiss KA, O'Hara MH. Brown TJ, et al. Among authors: reiss ka. Am Soc Clin Oncol Educ Book. 2023 May;43:e397082. doi: 10.1200/EDBK_397082. Am Soc Clin Oncol Educ Book. 2023. PMID: 37192430 Free article.
A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence.
Heumann TR, Baretti M, Sugar EA, Durham JN, Linden S, Lopez-Vidal TY, Leatherman J, Cope L, Sharma A, Weekes CD, O'Dwyer PJ, Reiss KA, Monga DK, Ahuja N, Azad NS. Heumann TR, et al. Among authors: reiss ka. Clin Epigenetics. 2022 Dec 3;14(1):166. doi: 10.1186/s13148-022-01367-8. Clin Epigenetics. 2022. PMID: 36463226 Free PMC article. Clinical Trial.
Multianalyte Prognostic Signature Including Circulating Tumor DNA and Circulating Tumor Cells in Patients With Advanced Pancreatic Adenocarcinoma.
Chapin WJ, Till JE, Hwang WT, Eads JR, Karasic TB, O'Dwyer PJ, Schneider CJ, Teitelbaum UR, Romeo J, Black TA, Christensen TE, Redlinger Tabery C, Anderson A, Slade M, LaRiviere M, Yee SS, Reiss KA, O'Hara MH, Carpenter EL. Chapin WJ, et al. Among authors: reiss ka. JCO Precis Oncol. 2022 Jul;6:e2200060. doi: 10.1200/PO.22.00060. JCO Precis Oncol. 2022. PMID: 35939771 Free PMC article.
58 results